Prospective cohort study of neoadjuvant chemotherapy using tri-weekly carboplatin and weekly paclitaxel for patients with locally advanced cervical cancer
Not Applicable
Recruiting
- Conditions
- cervical cancer
- Registration Number
- JPRN-UMIN000024136
- Lead Sponsor
- Hyogo Cancer CEnter
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. Previous chemotherapy. 2. Concomitant malignancy. 3. Severe complication.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 2 year recurrence free survival rate
- Secondary Outcome Measures
Name Time Method Response rate, Pathological CR rate, 2 year overall survival rate, Toxicity, Site of recurrence, Completion rate of the neoadjuvant chemotherapy